Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated CBT and sertraline trial for young people with depression and substance use
ACTRN12605000675628Phase 4Recruiting
- Sponsor
- Melbourne Health
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sertraline in major depressive disorder (MDD) and substance use disorder (SUD) (3 arms), sponsored by Melbourne Health. Primary endpoint: Symptomatic improvement. Started Jan 2005; status: recruiting.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)substance use disorder (SUD)
Beyond the preview
Go deeper on ACTRN12605000675628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000675628.